Purchase Order SPE2DP25V3319
- Not listed
- The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,005.03 firm fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The contract is for the delivery of naloxone hydrochloride, a critical medical supply. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that holds several federal contract...
- The U.S. Defense Logistics Agency awarded a firm-fixed-price purchase order contract worth $1,005.03 to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of naloxone hydrochloride. The contract has an ultimate completion date of August 14, 2024 and was awarded on July 30, 2024. The Maclean Group, an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor, has a diverse portfolio of federal...
- The U.S. Department of Defense's Medical Supply Chain has awarded a firm-fixed-price purchase order contract to The Maclean Group LLC, a service-disabled veteran-owned small business, for the supply of Naloxone Hydrochloride. The $5,025.15 contract has a completion date of May 13, 2024. The Maclean Group is a diversified government contractor that provides a range of products and services, including medical equipment, water treatment systems, and facility maintenance, to various federal agencies...
- The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,005.03 firm fixed price purchase order to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The award is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose, and has a period of performance through March 13, 2025. The Maclean Group, an ISO 9001:2015 certified medical and pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price purchase order contract worth $2,010.06 to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of naloxone hydrochloride. The contract has a performance period ending on May 13, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that provides a range of products and services to federal...
- This contract award to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, is for the supply of naloxone hydrochloride to the Department of Defense's Medical Supply Chain. The fixed-price purchase order has a ceiling value of $1,005.03 and a completion date of September 25, 2024. The Maclean Group has previously supplied a variety of medical equipment, water treatment systems, and support services to federal agencies...
- This $3,015.09 firm fixed-price purchase order was awarded to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Jacksonville, Florida. The contract was awarded by the Defense Logistics Agency's Medical Supply Chain Division for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has an ultimate completion date of December 9, 2024. The Maclean Group LLC is an ISO 9001:2015...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,010.06 firm-fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of 8510594132 - Naloxone Hydrochloride. The contract does not have a set-aside designation and has an ultimate completion date of May 10, 2024. The Maclean Group is a medical and pharmaceutical wholesale distributor that holds several significant federal...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,010.06 firm-fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of naloxone hydrochloride, a medication used to reverse opioid overdose. This contract has an ultimate completion date of May 13, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that holds several...
- This firm-fixed-price purchase order was awarded to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, to provide naloxone hydrochloride to the Defense Logistics Agency's Medical Supply Chain. The $1,005.03 contract has an ultimate completion date of August 1, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has been awarded multiple federal contracts, including a...
The U.S. Department of Defense's Medical Supply Chain has awarded a firm fixed-price purchase order totaling $2,010.06 to The Maclean Group LLC for the supply of naloxone hydrochloride. The award, issued on August 13, 2025, with an ultimate completion date of August 28, 2025, represents a small-value procurement with no set-aside designation. The Maclean Group, a service-disabled veteran-owned small business (SDVOSB) based in Sacramento, California, is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that specializes in providing critical medical supplies and equipment to federal agencies. The Maclean Group's selection reflects its established capabilities as a versatile federal contractor with extensive experience in pharmaceutical supply and medical equipment distribution. The company maintains multiple federal contract vehicles, including Federal Supply Schedule contracts with the Veterans Affairs Department and GSA for medical equipment and supplies, as well as additional indefinite delivery vehicles with the Navy and other defense entities. This purchase order for naloxone hydrochloride aligns with the contractor's core competency in pharmaceutical supply and supports the Department of Defense's operational medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/13/25 |